Skip to main content

Security report for pharmadeutschland.de

Pharma Deutschland e.V. · Healthcare · Germany

Medium risk. 5 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

58/100

Risk levelMedium

0–100, higher is better. How it is calculated

Pharma Deutschland e.V. is the largest pharmaceutical industry association in Germany, representing over 400 member companies. The organization focuses on advocacy, providing expert advice, publications, seminars, and member services to support the pharmaceutical sector. The website reflects a professional and well-structured digital presence, targeting industry stakeholders, policymakers, and the public. It offers multilingual support and a member login area, enhancing engagement and service delivery. Technically, the site is built on TYPO3 CMS, hosted on rzone.de infrastructure, and integrates modern tools such as Usercentrics for consent management and Matomo for privacy-conscious analytics. Security posture is strong with HTTPS enforcement and secure login mechanisms, though some security headers could be improved. Privacy compliance is robust, with clear GDPR-aligned policies and cookie consent mechanisms. Overall, the site demonstrates high business credibility and trustworthiness, with transparent contact information and active social media channels.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…
  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching pharmadeutschland.de

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
25
Email security
75
DNS health
65
Network security
40
GDPR outside view
68
Average
58

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention pharmadeutschland.de, from OffSeq Breach.

No leaked records found

Breach holds no records for pharmadeutschland.de right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Pharma Deutschland holds a leading market position as a key industry association in the German healthcare sector. Its business model centers on member representation, policy advocacy, and knowledge dissemination. The association leverages a broad partnership ecosystem, including digital platforms and social media, to maintain visibility and influence. Revenue streams likely include membership fees, event hosting, and publication sales. The website's content and structure indicate a mature organization with a focus on transparency and member engagement. Growth indicators include active event calendars and educational offerings. The association's presence in Bonn, Berlin, and Brussels underscores its strategic positioning within national and EU regulatory environments.

Security posture

The website exhibits a mature security posture with mandatory HTTPS and secure login forms using AJAX. The integration of a consent management platform ensures compliance with privacy regulations. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, the absence of explicit security headers like Content-Security-Policy and X-Frame-Options suggests room for enhancement. The use of self-hosted Matomo analytics reduces reliance on third-party trackers, improving privacy. Incident response and security policy documentation are not publicly visible, which could be improved to demonstrate readiness. Overall, the site balances usability and security effectively but should consider additional header implementations and regular security audits.

Recommendations

  1. Implement and enforce security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to mitigate common web vulnerabilities.
  2. Publish a clear security policy and incident response plan accessible to users and stakeholders to enhance transparency and preparedness.
  3. Regularly update TYPO3 CMS and all extensions to patch known vulnerabilities and maintain a secure environment.
  4. Enhance accessibility features to improve compliance with standards and broaden user inclusivity.
  5. Continue monitoring third-party scripts and consent mechanisms to ensure ongoing GDPR compliance and user trust.

Contact details published on the site

Addresses
Legal name
Pharma Deutschland e.V.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Pharma Deutschland e.V.
Description
Pharma Deutschland ist mit mehr als 400 Mitgliedsunternehmen der mitgliederstärkste Verband der pharmazeutischen Industrie in Deutschland. Die Pharmaindustrie ist eine gesunde, permanent innovative, hochrelevante Industrie mit starker Wertschöpfung. Pharma Deutschland sorgt dafür, dass die Pharmabranche im Gesundheitsbereich, in der Politik und der Öffentlichkeit als Leitbranche wahrgenommen wird.
Key services
Advocacy and representation, Publications and studies, Consulting and expertise, Seminars and training, Newsletter and member area
Content quality
good
Branding
consistent

Technology

Stack
TYPO3 CMS, jQuery, Usercentrics Consent Management Platform, Flockler social media embed, Matomo Analytics (self-hosted)
Frameworks
TYPO3 CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Use of consent management platform for privacy compliance
  • Login form uses AJAX with error handling
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Matomo Analytics (self hosted)
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo (self hosted)
Marketing tools
Usercentrics Consent Management Platform, Flockler social media embeds
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Uses modern CMS TYPO3 with professional design and clear navigation.
  3. Strong focus on pharmaceutical industry association content and member services.
  4. Includes GDPR-compliant privacy and cookie policies with consent management.
  5. Multiple contact methods and physical office addresses in Germany and Brussels.
  6. Social media presence on Instagram, LinkedIn, and YouTube.
  7. Self-hosted Matomo analytics for privacy-friendly tracking.
  8. No signs of suspicious or malicious content.
Technical notes

Notes

The website is built on TYPO3 CMS, a robust and widely used content management system, indicating a solid technical foundation. It uses jQuery and integrates Usercentrics for consent management and Flockler for social media embedding, reflecting modern web practices. Hosting is provided by rzone.de, a reputable German hosting provider. Performance is moderate with responsive design and mobile optimization evident. SEO is supported by proper meta tags and hreflang attributes for multilingual support. Accessibility is basic but could be improved. The site uses self-hosted Matomo analytics, enhancing privacy. Overall, the technical infrastructure is stable and well-suited for the organization's needs, with opportunities for modernization and security hardening.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with pharmadeutschland.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review pharmadeutschland.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.